Supplier News
Agilent Acquires Genohm to Improve Lab Informatics
Agilent Technologies expects the acquisition to improve its current software portfolio.
Integrated Dissolution Solution for R&D and QC Labs
Mettler Toledo and SOTAX partnered to develop a new dissolution solution system line for R&D and quality control laboratory processes.
Rentschler Fill Solutions Announces Agreement for US-Market Drug
Rentschler Fill Solutions and Ultragenyx announce fill and finish agreement for the US commercial supply of Mepsevii.
GE and CCRM Partner with DiscGenics on New Cell Therapy
GE Healthcare and the Centre for Commercialization of Regenerative Medicine (CCRM) will support scale-up efforts by DiscGenics for a new cell therapy intended to treat back pain.
Samsung BioLogics Receives FDA Approval for Biologic Drug Substance Manufacturing
This marks the third FDA approval for the company’s second biomanufacturing plant in Incheon, Korea.
FUJIFILM Adds Late-Phase and Commercial Fill/Finish Capabilities
In adding a Vanrx Pharmasystems aseptic filling isolator, FUJIFILM adds fill/finish for gene therapies and viral vaccines.
Gilead’s Kite Expands Cell Therapy Facilities in US, Europe
The company has leased and purchased facilities in the United States and Europe to expand its cell therapy pipeline.
Parker Bioscience Expands UK Facilities
Parker Bioscience will expand laboratory, cleanroom, office, and warehouse facilities at its Birtley, UK manufacturing site.
Catalent Adds Capacity at Kansas City Clinical Supplies Facility
The second phase of a $5.5-million expansion adds controlled-substance and controlled-temperature storage to Catalent clinical trials facility.
Novartis Acquires AveXis for $8.7 Billion
The acquisition is expected to strengthen Novartis’ gene therapy pipeline.
GE Increases Cell Culture Media Production Capacity
The company is increasing its cell culture media production capacity at its facilities in Pasching, Austria, and Logan, Utah.
Catalent to Develop Biosimilars for Valerius Biopharma
Valerius Biopharma will use Catalent’s GPEx technology to produce cell lines for biosimilar drugs.
Lonza, Proteon Therapeutics Extend API Manufacturing Partnership
The companies have extended a contract agreement for the commercial manufacture of the active pharmaceutical ingredient for vonapanitase, an investigational drug intended to improve hemodialysis vascular access outcomes.
Inventory Management Software Designed for Biopharma
InstantGMP INV is a validated software for real-time material tracking and inventory control in biopharmaceutical manufacturing.
Merck, Moderna Expand mRNA Cancer Vaccines Partnership
The companies expanded their partnership to develop and commercialize messenger RNA (mRNA) cancer vaccines to include shared-antigen mRNA cancer vaccines such as mRNA-5671.
J&J’s Janssen to Acquire BeneVir for $1 Billion
Johnson & Johnson’s Janssen Biotech will acquire biotechnology company BeneVir Biopharm to strengthen Janssen’s immunotherapy platform.
Lonza to Invest in Mid-Scale Biologics, Cell Therapy Manufacturing
Lonza announces addition of mid-scale biologics manufacturing capacity and cell-therapy suites at Portsmouth, NH site.
New Processing System Streamlines Cell Therapy Manufacturing
GE Healthcare’s new Sefia S-2000 cell processing system allows operators to conduct multiple cell therapy manufacturing steps with one instrument.
Avid Bioservices Expands Process-Development Capabilities
The company has begun expansion efforts for its process-development capabilities and laboratory infrastructure.
WuXi Biologics to Invest $389 Million in New Biomanufacturing Facility
The company will invest EUR 325 million (US$389 million) in a new biomanufacturing facility in Ireland using single-use bioreactors.
Haselmeier, Common Sensing to Partner on Injectable Solutions
The companies will partner to develop smart connected monitoring and support solutions for injectable drugs.
Fresenius Terminates $4.3-Billion Merger with Akron
Fresenius Kabi claims that Akorn failed to fulfill several closing conditions.
Astellas Sells Research Facilities to Gilead’s Kite Pharma
As Astellas Pharma winds down its Agensys research operations, the company sells the Santa Monica, CA, facility to Gilead.
Wyatt Technology Announces Executive Team Changes
Geofrey Wyatt has been named CEO and Clifford Wyatt named president of Wyatt Technology.
Selexis SA Invests in New Lab Equipment and Personnel
The company’s investment in new laboratory equipment and personnel will strengthen its cell line development services.
Nelson Labs Expands Lab Operations and Testing Capabilities
The company doubled capacity for laboratory services at its facility in Itasca, IL.
Thermo Fisher Showcases New Equipment at Analytica 2018
The company showcased newer products and equipment for cell culture laboratories at Analytica 2018 in Munich, Germany.
Patheon Doubles Biologics Capacity at St. Louis Facility
Thermo Fisher Scientific invests $50 Million to expand biologics drug development and manufacturing capabilities in St. Louis, MO.
Sanofi Buys Berkeley Lights’ Cell Line Platform
The new platform is expected to speed up cell line development.
WuXi AppTec Expands Drug Development Testing Services
The expanded Laboratory Testing Division, located in Cranbury, NJ, will expand the company’s testing services in the United States.
